Measurements of oxidative stress status and antioxidant activity in chronic leukaemia patients

被引:44
作者
Al-Gayyar, Mohammed M. H. [1 ]
Eissa, Laila A. [1 ]
Rabie, Ahmed M. [1 ]
El-Gayar, Amal M. [1 ]
机构
[1] Univ Mansoura, Fac Pharm, Dept Biochem, Mansoura 35516, Egypt
关键词
D O I
10.1211/jpp.59.3.0011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
There is an interactive relationship between leukaemia and oxidative stress. Leukaemic cells produce larger amounts of reactive oxygen species (ROS) than non-leukaemic cells as they are under a continual state of oxidative siege. So, this study was performed on 20 patients with chronic leukaemia from the Oncology Centre, Mansoura University. We measured leucocytic H2O2 concentrations and lipid peroxidation as serum malondialdehyde (MDA) concentration, serum total antioxidant activity, plasma ascorbic acid and dehydroascorbic acid concentrations, blood reduced glutathione concentration, haemolysate G6PD activity, blood catalase activity, serum superoxide dismutase (SOD) activity and serum anti-dsDNA concentration. We found that chronic leukaemia patients showed a significant increase (P < 0.05) in leucocytic H2O2, serum MDA concentration and total antioxidant activity either before or after treatment as compared with control group. Also, there was a significant increase in the other parameters (glutathione, catalase and SOD) either before or after treatment, but we found a significant decrease in ascorbic acid concentration and G6PD activity. There was a significant increase in anti-dsDNA concentration either before or after treatment. It can be concluded that leukaemic patients produce larger amounts of ROS than non-leukaemic patients. Also, the increase in antioxidant activity in leukaemic patients is not high enough to counteract the harmful effects of free radicals. This scenario becomes worse after administration of chemotherapy.
引用
收藏
页码:409 / 417
页数:9
相关论文
共 54 条
  • [1] Antioxidant status, erythrocyte membrane lipid peroxidation and osmotic fragility in malignant lymphoma patients
    Abou-Seif, MAM
    Rabia, A
    Nasr, M
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2000, 38 (08) : 737 - 742
  • [2] ASCORBIC-ACID (VITAMIN-C) MODULATES THE MUTAGENIC EFFECTS PRODUCED BY AN ALKYLATING AGENT IN-VIVO
    AIDOO, A
    LYNCOOK, LE
    LENSING, S
    WAMER, W
    [J]. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 1994, 24 (03) : 220 - 228
  • [3] Arruda VR, 1996, NEOPLASMA, V43, P99
  • [4] COPPER-ION-DEPENDENT DAMAGE TO THE BASES IN DNA IN THE PRESENCE OF HYDROGEN-PEROXIDE
    ARUOMA, OI
    HALLIWELL, B
    GAJEWSKI, E
    DIZDAROGLU, M
    [J]. BIOCHEMICAL JOURNAL, 1991, 273 : 601 - 604
  • [5] Glucose-6-phosphate dehydrogenase deficiency and hematopoietic stem cell transplantation
    Au, WY
    Ma, SK
    Lie, AKW
    Liang, R
    Cheng, T
    Kwong, YL
    [J]. BONE MARROW TRANSPLANTATION, 2002, 29 (05) : 399 - 402
  • [6] Azizova OA, 1997, GEMATOL TRANSFUZIOL, V42, P3
  • [7] Glutathione peroxidase, glutathione reductase, Cu-Zn superoxide dismutase activities, glutathione, nitric oxide, and malondialdehyde concentrations in serum of patients with chronic lymphocytic leukemia
    Bakan, N
    Taysi, S
    Yilmaz, Ö
    Bakan, E
    Kuskay, S
    Uzun, N
    Gündogdu, M
    [J]. CLINICA CHIMICA ACTA, 2003, 338 (1-2) : 143 - 149
  • [8] THE CHRONIC MYELOID LEUKEMIAS - GUIDELINES FOR DISTINGUISHING CHRONIC GRANULOCYTIC, ATYPICAL CHRONIC MYELOID, AND CHRONIC MYELOMONOCYTIC LEUKEMIA - PROPOSALS BY THE FRENCH-AMERICAN-BRITISH-COOPERATIVE-LEUKEMIA-GROUP
    BENNETT, JM
    CATOVSKY, D
    DANIEL, MT
    FLANDRIN, G
    GALTON, DAG
    GRALNICK, H
    SULTAN, C
    COX, C
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1994, 87 (04) : 746 - 754
  • [9] BEUTLER E, 1963, J LAB CLIN MED, V61, P882
  • [10] Carr AC, 1999, AM J CLIN NUTR, V69, P1086